Waypoint Capital taps ex-Sanofi CEO to lead healthcare fund
Waypoint Capital has named Christopher A. Viehbacher as managing partner of its healthcare-focused Gurnet Point Capital fund. His appointment becomes effective July 1. Previously, Viehbacher was CEO of Sanofi and chairman of Genzyme.



